Autonomous Medical Devices (AMDI), originally known as Sensor-Kinesis Corp. (SKC), was founded with the mission to revolutionize point-of-care testing through advanced microfluidics and protein engineering. The company specializes in developing proprietary, flexible microbiosensors that can detect and measure biological signals from humans. These sensors are designed for integration with smart devices, allowing for real-time data transmission and analysis via cloud technology. AMDI's products target diverse industries, including healthcare and molecular diagnostics, aiming to provide low-cost, portable disease detection solutions.

Notable affiliated individuals include experts in microfluidics and protein engineering, although specific names are not provided. AMDI has garnered significant attention and funding, including a $5.3 million NIH RAD® Tech Award to finalize their innovative technologies. The company's key achievements include developing next-generation point-of-care testing solutions that eliminate sample preparation delays. Overall, AMDI's impact lies in its potential to transform disease detection and diagnostics, making healthcare more accessible and efficient.